论文部分内容阅读
作者对63例晚期肺癌,包括手术或放射治疗失败者,作姑息性免疫—化疗,取得较好结果。其中鳞癌32例、小细胞癌20例、腺癌11例。男性共61例,平均年龄58岁。治疗方案包括两部份:甲方案为每四周作一次大剂量联合化疗,根据细胞类型:鳞癌选用丝裂霉素0.25毫克/公斤、阿霉素60毫克/平方米、氨甲喋呤40毫克/平方米、环乙亚硝脲(CCNU)60毫克/平
The authors performed palliative immunity-chemotherapy in 63 patients with advanced lung cancer, including those who failed surgery or radiation therapy, and achieved better results. Among them, there were 32 cases of squamous cell carcinoma, 20 cases of small cell carcinoma, and 11 cases of adenocarcinoma. A total of 61 males were with an average age of 58 years. The treatment plan consists of two parts: The first one is a high-dose combination chemotherapy every four weeks. According to the cell type: squamous cell carcinoma, mitomycin 0.25 mg/kg, doxorubicin 60 mg/m2, methotrexate 40 mg/m2 , Central nitrosourea (CCNU) 60 mg / ping